142 related articles for article (PubMed ID: 27279187)
1. Fairer way to distribute last-ditch drugs gets real-world trial.
Reardon S
Nature; 2016 Jun; 534(7606):160-1. PubMed ID: 27279187
[No Abstract] [Full Text] [Related]
2. The Ethical Challenges of Compassionate Use.
Caplan AL; Ray A
JAMA; 2016 Mar; 315(10):979-80. PubMed ID: 26868205
[No Abstract] [Full Text] [Related]
3. Expanded Access to Investigational Drugs: What Physicians and the Public Need to Know about FDA and Corporate Processes.
Finkelstein PE
AMA J Ethics; 2015 Dec; 17(12):1142-6. PubMed ID: 26698587
[No Abstract] [Full Text] [Related]
4. Food and Drug Administration responds to pressure for expanded drug access.
Brower V
J Natl Cancer Inst; 2014 Jun; 106(6):dju171. PubMed ID: 24907387
[No Abstract] [Full Text] [Related]
5. Patient advocacy. 'Right to Try' laws bypass FDA for last-ditch treatments.
Servick K
Science; 2014 Jun; 344(6190):1329. PubMed ID: 24948714
[No Abstract] [Full Text] [Related]
6. Fair, just and compassionate: A pilot for making allocation decisions for patients requesting experimental drugs outside of clinical trials.
Caplan AL; Teagarden JR; Kearns L; Bateman-House AS; Mitchell E; Arawi T; Upshur R; Singh I; Rozynska J; Cwik V; Gardner SL
J Med Ethics; 2018 Nov; 44(11):761-767. PubMed ID: 29982174
[TBL] [Abstract][Full Text] [Related]
7. Questions of Safety and Fairness Raised as Right-to-Try Movement Gains Steam.
Jacob JA
JAMA; 2015 Aug; 314(8):758-60. PubMed ID: 26244653
[No Abstract] [Full Text] [Related]
8. The strange allure of state "right-to-try" laws.
Zettler PJ; Greely HT
JAMA Intern Med; 2014 Dec; 174(12):1885-6. PubMed ID: 25264589
[No Abstract] [Full Text] [Related]
9. Attorneys aim to reform "compassionate use": groups say the regulatory system lags behind scientific advances.
Printz C
Cancer; 2015 Jan; 121(2):163-4. PubMed ID: 25581115
[No Abstract] [Full Text] [Related]
10. Expanded access rules pose quandary for drug developers.
Mack GS
Nat Biotechnol; 2009 Oct; 27(10):871-2. PubMed ID: 19816423
[No Abstract] [Full Text] [Related]
11. "Right to Try" laws.
Begg CB; Kim K; Neaton JD
Clin Trials; 2014 Oct; 11(5):519-20. PubMed ID: 25190026
[No Abstract] [Full Text] [Related]
12. The Federal Right to Try Act of 2017-A Wrong Turn for Access to Investigational Drugs and the Path Forward.
Bateman-House A; Robertson CT
JAMA Intern Med; 2018 Mar; 178(3):321-322. PubMed ID: 29356821
[No Abstract] [Full Text] [Related]
13. FDA approves three different multiple myeloma drugs in one month.
Ratner M
Nat Biotechnol; 2016 Feb; 34(2):126. PubMed ID: 26849508
[No Abstract] [Full Text] [Related]
14. The limits of free speech.
Nature; 2012 Dec; 492(7429):311. PubMed ID: 23281497
[No Abstract] [Full Text] [Related]
15. From the Food and Drug Administration.
Nightingale SL
JAMA; 1995 Oct; 274(14):1109. PubMed ID: 7563473
[No Abstract] [Full Text] [Related]
16. 'Biosimilar' drugs poised to penetrate market.
Ledford H
Nature; 2010 Nov; 468(7320):18-9. PubMed ID: 21048737
[No Abstract] [Full Text] [Related]
17. Arthur Caplan.
Nat Rev Drug Discov; 2016 Apr; 15(4):226-7. PubMed ID: 27032827
[No Abstract] [Full Text] [Related]
18. Patients, physicians, and clinical trials: the other side of the coins.
Abramson SB; Flexner C; Snyderman R; Dieterich DT; Korn D; Temple R; Sherwood L; Goldblatt D
J Investig Med; 1999 Sep; 47(8):343-57. PubMed ID: 10510587
[No Abstract] [Full Text] [Related]
19. [The industrial future small batches].
Conduzorgues JP
Presse Med; 2012 May; 41 Suppl 1():S55-6. PubMed ID: 22480860
[No Abstract] [Full Text] [Related]
20. Tempered enthusiasm. Drug-safety law needs more teeth, patient-safety advocates say.
DerGurahian J
Mod Healthc; 2007 Oct; 37(40):16. PubMed ID: 18018373
[No Abstract] [Full Text] [Related]
[Next] [New Search]